Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

NSAID gastropathy. A new understanding

S H Roth1

  • 1Arthritis Center Ltd, Phoenix, Ariz, USA.

Archives of Internal Medicine
|August 12, 1996
PubMed
Summary

Nonsteroidal anti-inflammatory drug (NSAID) gastropathy poses significant risks. Identifying at-risk patients and using gastroprotective strategies, like misoprostol, can mitigate NSAID-related gastrointestinal harm.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Whose pain is it anyhow?

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
Same author

Finessing fibromyalgia.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2006
Same author

Anoxic depolarization of rat hippocampal slices is prevented by thiopental but not by propofol or isoflurane.

British journal of anaesthesia·2005
Same author

Small-dose pentobarbital enhances synaptic transmission in rat hippocampus.

Anesthesia and analgesia·2001
Same author

Arthritis therapy: a better time, a better day.

Rheumatology (Oxford, England)·2001
Same author

Effects of repeated hydrogen sulphide (H2S) exposure on learning and memory in the adult rat.

Neurotoxicology·2001

Area of Science:

  • Gastroenterology
  • Pharmacology

Background:

  • Nonsteroidal anti-inflammatory drug (NSAID) gastropathy leads to significant morbidity, mortality, and healthcare costs.
  • Risk factors for NSAID gastropathy include advanced age and prior gastrointestinal disease.

Purpose of the Study:

  • To define risk factors for NSAID gastropathy.
  • To evaluate strategies for preventing and managing NSAID-induced gastrointestinal complications.

Main Methods:

  • Review of identified risk factors for NSAID gastropathy.
  • Assessment of gastroprotective agents and newer NSAID safety profiles.

Main Results:

  • Older NSAIDs require careful formulation selection and lowest effective doses.
  • Gastroprotective cotherapy, such as misoprostol, is recommended for high-risk patients on older NSAIDs.
  • Newer NSAIDs may offer an improved gastrointestinal safety profile.

Conclusions:

  • Informed NSAID selection should balance risk-benefit and cost-benefit considerations.
  • Strategies exist to minimize NSAID-related gastrointestinal adverse events.

Related Experiment Videos